While receiving a morning report from the night shift about a patient who has developed Atrial Fibrillation with Rapid Ventricular Response (Afib with RVR), the nurse expects that specific medications may be ordered by the physician to control the heart rate. Which medications are typically ordered to control the rapid response?

Choice A rationale In atrial fibrillation with rapid ventricular response, the goal is to slow the conduction through the atrioventricular node to decrease the heart rate. Calcium channel blockers like diltiazem and beta-blockers like metoprolol are first-line agents for rate control. Digoxin provides rate control by increasing vagal tone, while amiodarone is an antiarrhythmic that can help with both rate and rhythm. These medications help maintain a stable heart rate, typically targeted below 100 beats per minute. Choice B rationale Epinephrine, atropine, and norepinephrine are generally used to increase heart rate or blood pressure in cases of symptomatic bradycardia or distributive shock. Using these in a patient with atrial fibrillation and rapid ventricular response would be dangerous, as they would further increase the ventricular rate, significantly decrease diastolic filling time, and potentially lead to hemodynamic collapse or myocardial ischemia. These medications are contraindicated when the clinical goal is to achieve ventricular rate reduction. Choice C rationale Angiotensin converting enzyme inhibitors and hydralazine are primary treatments for managing hypertension and chronic heart failure by reducing systemic vascular resistance. While they help with long-term cardiac remodeling and blood pressure control, they do not possess the electrophysiological properties required to slow the conduction through the atrioventricular node. Therefore, they are not effective or indicated for the acute management of rapid ventricular rates associated with atrial fibrillation or other supraventricular tachycardias. Choice D rationale Furosemide, spironolactone, and bumetanide are diuretics used to manage fluid volume overload by increasing the excretion of sodium and water by the kidneys. While patients in atrial fibrillation may eventually develop heart failure symptoms requiring diuresis, these drugs do not have any direct effect on the heart's electrical conduction system or the ventricular rate. They are not used as primary agents to control the rapid heart rate seen in atrial fibrillation with RVR.